Breaking News Instant updates and real-time market news.

CARA

Cara Therapeutics

$17.96

0.12 (0.67%)

16:21
08/07/18
08/07
16:21
08/07/18
16:21

Cara Therapeutics reports Q2 EPS (52c), consensus (32c)

Reports Q2 revenue $2.87M, consensus $6.47M.

  • 07

    Aug

  • 30

    Aug

  • 31

    Aug

CARA Cara Therapeutics
$17.96

0.12 (0.67%)

05/23/18
HCWC
05/23/18
NO CHANGE
Target $24
HCWC
Buy
H.C. Wainwright says Cara found 'best possible' partner, ups target to $24
H.C. Wainwright analyst Oren Livnat said Cara Therapeutics selected the "best possible partner to maximize IV Korsuva" in signing an agreement with the Vifor/Fresenius joint venture. He views the deal as a "clear positive," stating that it brings in minimally dilutive financing, validates Korsuva, and de-risks the U.S. commercial launch. Livnat increased his price target on Cara shares to $24 from $22 and keeps a Buy rating on the stock.
06/27/18
NEED
06/27/18
NO CHANGE
NEED
Cara Therapeutics price target raised to $28 from $23 at Needham
Needham analyst Alan Carr maintained a Buy rating on Cara Therapeutics and raised his price target on shares to $28 from $23, following positive results from Cara's Phase 3 trial of IV CR845 in Post-Surgical Pain, which met its primary endpoint and showed statistically significant impact on Post-Operative Nausea and Vomiting.
06/28/18
HCWC
06/28/18
NO CHANGE
Target $26
HCWC
Cara Therapeutics price target raised to $26 from $24 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat raised his price target for Cara Therapeutics to $26 saying the company yesterday surprised the Street with a positive IV CR845 Phase 2/3 postoperative pain study. The positive pain trial "certainly adds upside optionality to the story," Livnat tells investors in a research note. He notes, however, that there remains several open questions about the product profile regarding efficacy and potential indication to pursue. Livnat keeps a Buy rating on Cara.
06/28/18
NEED
06/28/18
NO CHANGE
Target $28
NEED
Buy
Cara Therapeutics price target raised to $28 from $23 at Needham
Needham analyst Alan Carr raised his price target on Cara Therapeutics to $28 and kept his Buy rating, citing the company's update on Phase 3 trial of IV CR845 in post-surgical pain. Carr notes that while the low dose missed statistical significance, it trended favorably relative to placebo, and the high dose met the primary endpoint of pain relief. The analyst sees the profile of CR845 as attractive with effective pain relief, low addiction, and low nausea side effects.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$43.61

0.47 (1.09%)

, AMZN

Amazon.com

$1,917.14

7.41 (0.39%)

12:04
06/20/19
06/20
12:04
06/20/19
12:04
Hot Stocks
Comcast to launch Amazon Music on Xfinity services »

Comcast (CMCSA) announced…

CMCSA

Comcast

$43.61

0.47 (1.09%)

AMZN

Amazon.com

$1,917.14

7.41 (0.39%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 10

    Jul

  • 25

    Jul

WORK

Slack Technologies

$0.00

(0.00%)

12:00
06/20/19
06/20
12:00
06/20/19
12:00
Syndicate
Breaking Syndicate news story on Slack Technologies »

Slack Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$7.07

-1.04 (-12.82%)

12:00
06/20/19
06/20
12:00
06/20/19
12:00
Hot Stocks
Britannia Bulk falls -13.3% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$29.48

-4.73 (-13.83%)

12:00
06/20/19
06/20
12:00
06/20/19
12:00
Hot Stocks
Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -13.9% »

Direxion Daily Junior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PIR

Pier 1 Imports

$10.11

9.4359 (1,399.78%)

12:00
06/20/19
06/20
12:00
06/20/19
12:00
Hot Stocks
Pier 1 Imports falls -24.6% »

Pier 1 Imports is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$198.00

23.43 (13.42%)

12:00
06/20/19
06/20
12:00
06/20/19
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 13.7% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$11.06

1.36 (14.02%)

12:00
06/20/19
06/20
12:00
06/20/19
12:00
Hot Stocks
Direxion Daily Jr Gld Mnrs Bull 3X Shrs rises 13.9% »

Direxion Daily Jr Gld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TUFN

Tufin

$25.38

3.32 (15.05%)

12:00
06/20/19
06/20
12:00
06/20/19
12:00
Hot Stocks
Tufin rises 14.1% »

Tufin is up 14.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WU

Western Union

$19.80

0.09 (0.46%)

11:55
06/20/19
06/20
11:55
06/20/19
11:55
Options
Western Union put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJRI

BJ's Restaurants

$43.84

2.53 (6.12%)

11:55
06/20/19
06/20
11:55
06/20/19
11:55
Conference/Events
BJ's Restaurants management to meet with Stephens »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 25

    Jun

  • 27

    Jun

11:50
06/20/19
06/20
11:50
06/20/19
11:50
General news
Treasury's $75 B in 4- and 8-week bill auctions were well received »

Treasury's $75 B in…

BRKR

Bruker

$48.19

0.45 (0.94%)

11:49
06/20/19
06/20
11:49
06/20/19
11:49
Earnings
Bruker sees medium-term EPS growth of 11%-15%, organic revenue growth of 5%-7% »

Sees FY22 EPS of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 06

    Sep

GO

Grocery Outlet

$0.00

(0.00%)

11:46
06/20/19
06/20
11:46
06/20/19
11:46
Syndicate
Breaking Syndicate news story on Grocery Outlet »

Grocery Outlet opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BRKR

Bruker

$48.08

0.34 (0.71%)

11:45
06/20/19
06/20
11:45
06/20/19
11:45
Earnings
Bruker sees FY19 EPS $1.57-$1.61, consensus $1.61 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 06

    Sep

ZUO

Zuora

$15.64

-0.27 (-1.70%)

11:45
06/20/19
06/20
11:45
06/20/19
11:45
Options
Zuora call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WORK

Slack Technologies

$0.00

(0.00%)

11:44
06/20/19
06/20
11:44
06/20/19
11:44
Syndicate
Breaking Syndicate news story on Slack Technologies »

Slack Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSNL

Personalis

$0.00

(0.00%)

11:42
06/20/19
06/20
11:42
06/20/19
11:42
Syndicate
Breaking Syndicate news story on Personalis »

Personalis opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

UAA

Under Armour

$26.88

-0.08 (-0.30%)

11:40
06/20/19
06/20
11:40
06/20/19
11:40
Conference/Events
Under Armour management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

SHOP

Shopify

$330.32

2.92 (0.89%)

11:39
06/20/19
06/20
11:39
06/20/19
11:39
Recommendations
Shopify analyst commentary  »

Shopify price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

HSY

Hershey

$137.38

-0.56 (-0.41%)

, SHOP

Shopify

$328.25

0.85 (0.26%)

11:37
06/20/19
06/20
11:37
06/20/19
11:37
On The Fly
Apple initiation, Shopify downgrade among today's top analyst calls »

Check out today's top…

HSY

Hershey

$137.38

-0.56 (-0.41%)

SHOP

Shopify

$328.25

0.85 (0.26%)

TSLA

Tesla

$220.25

-6.11 (-2.70%)

AMRN

Amarin

$19.69

0.27 (1.39%)

AAPL

Apple

$198.73

0.86 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 28

    Sep

11:36
06/20/19
06/20
11:36
06/20/19
11:36
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

11:36
06/20/19
06/20
11:36
06/20/19
11:36
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

AKRO

Akero Therapeutics

$0.00

(0.00%)

11:34
06/20/19
06/20
11:34
06/20/19
11:34
Syndicate
Breaking Syndicate news story on Akero Therapeutics »

Akero Therapeutics opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

AKRO

Akero Therapeutics

$0.00

(0.00%)

11:32
06/20/19
06/20
11:32
06/20/19
11:32
Syndicate
Breaking Syndicate news story on Akero Therapeutics »

Akero Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

TYPE

Monotype Imaging

$17.90

1.41 (8.55%)

11:30
06/20/19
06/20
11:30
06/20/19
11:30
Recommendations
Monotype Imaging analyst commentary  »

Private equity buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.